Skip to content

An exploratory study in developing a diagnostic method for skin disease by using the photoacoustic imaging system.

An exploratory study in developing a diagnostic method for skin disease by using the photoacoustic imaging system. - An exploratory study in developing a diagnostic method for skin disease by using the photoacoustic imaging system.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022767
Enrollment
30
Registered
2016-09-13
Start date
2016-09-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected cases of vascular lesions

Interventions

Sponsors

Kyoto University
Lead Sponsor
Canon Inc.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who visited our hospital, and healthy volunteers. 2. Patients who aged over 20 years and older at the time of informed consent. 3. Patients who have agreed to participate in this study from their own free will with document consents.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating patients 2. Patients who takes photosensitizer for photodynamic therapy 3. Patients with a cardiac pacemaker 4. Patients who are in poor general status 5. People who have any following complications in assessment body parts: Open wounds, excoriations, acnes, surgical wounds. Infected wounds. Infections. Neurological diseases and orthopedic disorders in which it is impossible to keep sitting or standing position. 6. People who have any following history of disorders: Mental disorders. Dementia. 7. Patients who are judged ineligible to enroll into this clinical study by the investigator or the sub-investigators due to limitations in taking examination position and other reasons.

Design outcomes

Primary

MeasureTime frame
Images acquired by the photoacoustic imaging system

Secondary

MeasureTime frame
Incidence of adverse events by using the photoacoustic imaging system. (Final monitoring is conducted within 90 days after intervention)

Countries

Japan

Contacts

Public ContactYoshihiro Ishida

Kyoto University Graduate school of Medicine Department of Dermatology

dermamed@kuhp.kyoto-u.ac.jp075-751-3310

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026